Citations

Clear

32 citation(s) found for "Stoll, W".

Assessment of Perceptions and Practices in Primary Care Providers Regarding Opportunistic Salpingectomy
Tischer, Kristin M. , Steiner, Amanda, Kelly, Camry , Stoll, Rebecca, Mohamed, Fahma , Selladurai, Roshini, Berbari, Elie, Hurt, Ryan, Kumar, Amanika, Bakkum-Gamez, Jamie N., Ehman, Katherine, Stoll, Rebecca , Selladurai, Roshini I. , Tischer, Kristin M. , Berbari, Elie F. , Bakkum‐Gamez, Jamie N.

Mayo Clinic

Journal of Primary Care & Community Health | August 12, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261474095 | PMID 42586533 Get It

Introduction/Objective Opportunistic salpingectomy (OS) has been shown to reduce high-grade serous ovarian cancer (HGSOC) by 42-80%, yet awareness of this strategy outside of obstetrics and gynecology remains limited. The objective of this study was to assess awareness and counseling practices regarding OS for HGSOC prevention among primary care providers (PCPs). Methods We conducted a cross-sectional survey study using a 6-item electronic survey evaluating PCP knowledge and counseling practices related to HGSOC prevention through OS. The study was conducted at a single tertiary care center with gynecologic oncology services. Survey items assessed awareness of HGSOC origin, awareness of OS as a preventative strategy, counseling frequency in the setting of abdominal or pelvic surgery, counseling comfort, and resources needed to increase confidence in recommending OS. Response formats included Likert scales and Yes/No/Unsure options. The survey was distributed by email to attending physicians and advanced practice providers (APPs) in the Department of Family Medicine (FM) and Internal Medicine (IM). Results Of 398 providers surveyed, 136 responded (34% overall response rate; FM 44%, IM 28%), including 96 attending physicians and 40 APPs. Most PCPs were unaware that HGSOC originates in the fallopian tubes (60%) and were unaware of OS as a preventive strategy (71%). Counseling was uncommon: 11% had ever counseled on OS, while 74% had not and 15% reported it was outside their scope. Most respondents (63%) reported being not at all comfortable counseling patients about OS. Providers identified clinical guidelines (60%), CME or training modules (50%), eligibility criteria (48%), gynecology collaboration pathways (48%), and patient-friendly materials (44%) as key supports to improve counseling confidence. Conclusion PCP awareness and counseling regarding OS are limited. Given that guideline support for OS has solidified only in recent years, these gaps are not surprising—and they represent a clear, actionable opportunity. PCPs are well-positioned to lead the expansion of ovarian cancer prevention beyond specialty care with the right tools and support.
The Impact of Age-Associated Lymph Node Microenvironment Changes On Dendritic Cell:CD4+ T Cell Interactions During Germinal Center Initiation 2255775
Stoll, Carly, Lancaster, Jessica, Stoll, Carly R. , Lancaster, Jessica N.

Mayo Clinic

The Journal of Immunology | July 28, 2026 | Volume: 215 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkag141.281 Get It

Abstract Introduction Germinal center (GC) formation in lymph node (LN) follicles is essential for generating high-affinity antibodies following infection or vaccination. This response in aging is impaired, resulting in smaller and fewer GCs that generate less abundant antibodies with reduced antigen affinities as compared to young adults. Early GC formation depends on dendritic cell (DC)-mediated activation of naïve CD4+ T cells, which differentiate into CD4+ T follicular helper (TFH) cells that drive B cell responses. Antigen-specific TFH induction is mediated by type 2 conventional DCs, which localize to the T:B cell interfollicular boundaries. Live-cell 2-photon microscopy has previously revealed that T cell priming by DCs occurs in distinct phases of lasting versus intermittent interactions, though the quality and duration of DC:CD4+ T cell interactions has not been characterized in aged hosts. We hypothesize that age-associated alterations in LN microenvironments disrupt these interactions, leading to impaired GC formation. Methods Young and aged mice were subcutaneously immunized in the flank with nitrophenyl hapten conjugated to ovalbumin in alum adjuvant, and naïve OT-II CD4+ T cells were adoptively transferred via retroorbital injection. 48 hours after immunization, draining LNs and naïve controls were analyzed by multiplex immunofluorescence microscopy to map the spatial organization of DCs and stromal elements. Results Structural mapping showed disrupted alignment of stromal networks, suggesting impaired spatial compartmentalization of the aged microenvironment. Moreover, within aged immunized mice the localization of DCs within the interfollicular region and T:B cell zone borders of the LNs were altered. Conclusion Our findings suggest age-associated disruption of the LN microarchitecture diminishes the quality of DC:CD4+ T cell interactions essential for initiating GCs. These insights highlight tissue microenvironmental remodeling as a key contributor to age-related immune decline. Funding Source NIH Topic Categories Lymphocyte Differentiation and Peripheral Maintenance (LYM)
MHC class II on melanoma cells regulates the anti-tumor T cell response
Macy, Anne M. , Herrmann, Lauren M , Thornley, Erin M. , Adams, Anngela C. , Stoll, Carly R. , Lancaster, Jessica N. , Hastings, Karen Taraszka , Hastings, K Taraszka , Lancaster, Jessica N

Mayo Clinic

The Journal of Immunology | June 29, 2026 | Volume: 215 | Issue: 6 | Pages: No page available

10.1093/jimmun/vkag158 | PMID 42372115 Get It

Abstract In human melanoma, tumor cell-specific MHC class II expression is associated with improved response to programmed death 1 and programmed death-ligand 1 blockade; yet the direct effect of melanoma cell-specific MHC class II expression on anti-melanoma T cell responses remains largely unknown. In the clinically relevant Yale University Mouse Melanoma Exposed to Radiation (YUMMER) cell lines, MHC class II expression was IFN-γ-inducible in a subset of cells. Transduction of melanoma cells with CIITA resulted in uniformly high, constitutive expression of MHC class II. YUMMER.G cells transduced with CIITA vector had increased in vivo tumor growth in wild-type mice compared to melanoma cells transduced with empty vector. YUMMER.G cells transduced with empty or CIITA vectors had the same in vivo tumor growth in RAG−/− mice, indicating that the difference in tumor growth between CIITA- and empty-transduced cells was dependent on an intact adaptive immune system. CIITA-transduced YUMMER.G tumors exhibited an increased frequency and infiltration depth of CD4+ T cells, an increased frequency of T regulatory cells, and a decreased frequency and infiltration depth of CD8+ T cells, compared to empty-transduced tumors. Antibody depletion revealed that CIITA- and empty-transduced YUMMER.G tumors were constrained by CD4+ and CD8+ T cells, but only tumor growth of CIITA-transduced cells was decreased by CD25 blockade, which primarily blocks T regulatory cell function. Overall, this work reveals a potential pro-tumorigenic role of melanoma cell-specific overexpression of MHC class II.
Treatment Challenges in a Complex Presentation of Diabetic Ketoacidosis, Hyperosmolar Hyperglycemic Syndrome and Hypernatremia: A Case Report
Dhamelia, Parth , Mulville, Sara, Lester, Peyton, Skinner, Preston, Stoll, Nicolas Tapia, Baptista, Aleksandra Murawska , Singla, Abhinav , Tapia Stoll, Nicolas , Tapia-Stoll, Nicolas

Mayo Clinic

Journal of Diabetes and Clinical Research | June 8, 2026 | Volume: 8 | Issue: 1 | Pages: 22

10.33696/diabetes.8.076 Get It

Background: Overlap between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) is associated with significantly higher mortality than either condition alone. While hypertonic (trans locational) hyponatremia is common in hyperglycemic crises, clinically significant hypernatremia in mixed DKA/HHS presents with certain treatment challenges due to rapid osmotic shifts during insulin therapy. Case presentations: A 40-year-old woman with non-significant past medical history presented with vomiting, polyuria, polydipsia, and confusion for two days. Laboratory evaluation revealed serum glucose 1280 mg/dL, arterial pH 7.214, bicarbonate 13.1 mmol/L, anion gap 24, β-hydroxybutyrate 6.0 mmol/L, corrected sodium 152 mmol/L (measured sodium 133 mmol/L), and calculated effective osmolality 337 mOsm/kg. Initial treatment with isotonic saline and intravenous insulin led to improvement in hyperglycemia but worsening corrected hypernatremia to 160 mmol/L after 3 liters of normal saline. Free water deficit was calculated at 6.3 L. Fluid therapy was transitioned to hypotonic solutions with titration to limit sodium correction to ≤10 mmol/L per 24 hours. Sodium levels gradually normalized with resolution of ketoacidosis, and improvement in mental status without significant neurologic complications. Conclusion: In mixed DKA/HHS, early assessment of corrected sodium and effective osmolality is critical. Insulin-mediated intracellular water shifts may unmask or worsen hypernatremia. Prompt reassessment of corrected sodium and individualized fluid management is needed to avoid treatment-related exacerbation of hypertonicity.
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001
Chiorean, E. Gabriela , Damle, Sheela , Zhen, David B. , Whittle, Martin, George, Ben, HOCHSTER, H, Coveler, Andrew L. , Hendifar, Andrew E, Safyan, Rachael A. , King, Gentry Teng , Harris, William P., Dion, Barbara, D’Astice, Amy Stoll, Lee, Arthur, Thorsen, Shelley M., Kugel, Sita , Rosenthal, A., Chiorean, E Gabriela , Damle, Sheela R , Safyan, Rachael A , George, Ben , Hendifar, Andrew , Dragovich, Tomislav , Harris, William P., Stoll-D’Astice, Amy, Hingorani, Sunil R.

Mayo Clinic

Cancers | February 3, 2026 | Volume: 18 | Issue: 3 | Pages: 507

10.3390/cancers18030507 | PMID 41681979 Get It

Background: Stromal hyaluronic acid (HA) poses a physical barrier and protects tumor cells from immune surveillance. Stroma targeting with pegylated human recombinant PH20 hyaluronidase (PEGPH20) demonstrated improved infiltration of cytotoxic T-lymphocytes and delivery of chemotherapy and PD1/PD-L1 antibodies in tumor models. This multicenter phase II study of PEGPH20 plus pembrolizumab evaluated the efficacy, safety and immune and stromal biomarkers in patients with HA-high refractory metastatic pancreatic ductal adenocarcinoma (mPDA). Patients and Methods: Patients were treated with PEGPH20 3 µg/kg IV weekly and pembrolizumab 200 mg IV in 3-week cycles. Tumor and blood samples were collected at baseline and on-study for biomarker analyses. Results: Between May and November 2019, 38 patients were screened and 8 treated, with median age 68 years (range 60–73) and median two (range 1–4) prior therapies. The study was closed to accrual early by pharmaceutical sponsor. Treatment was well tolerated, with expected grade 1/2 musculoskeletal toxicities. Best response was stable disease in 2 of 7 evaluable patients (29%). Median overall and progression-free survival were 7.2 months (95% CI 1.2–11.8) and 1.5 months (95% CI 0.9–4.4), respectively. Prolonged survival (range 10.2–27.6 months) occurred in patients treated with subsequent chemotherapy. Higher baseline tumor T cell receptor (TCR) clonality correlated with longer survival. Conclusions: Pembrolizumab with PEGPH20 was safe but did not have significant efficacy in refractory HA-high metastatic PDA.
Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Santiago-Carvalho, Igor , Francisco, Ronaldo da Silva , Macedo, Bruna de Gois , Salgado, Caio Loureiro , Stoll, Carly R. , Shao, Samantha C. , Beniwal, Angad , Kwok, Tina , Banuelos, Alma , Cione, Marcos Pinheiro , White, Emily , Johnston, Tyler, Leff, Chloe , Silva-Junior, Ildefonso , Souza, Fabio Carvalho de, Thant, Win , Fernandez-Bussy, Sebastian, Abia-Trujillo, David, Vu, Linh H, Husta, Bryan C, Copland, John A. , Gounari, Fotini , Justilien, Verline , Cione, Marcos Vinícios Pinheiro , Francisco, Ronaldo , Macedo, Bruna Gois , Johnston, Tyler M , Leff, Chloe Liliana , Carvalho de Souza, Fabio , Pandya, Prita , D'Império Lima, Maria Regina , Fernandez-Bussy, Sebastian , Abia-Trujillo, David , Vu, Linh H , Tran, Nhan L , Husta, Bryan C , Copland, John A , Gounari, Fotini , Justilien, Verline , Lancaster, Jessica N , Borges da Silva, Henrique , Silva, Ildefonso , Pandya, Prita , Lima, Maria Regina D’Império , Tran, Nhan L. , Lancaster, Jessica N. , Silva, Henrique Borges da

Mayo Clinic

Cancer Immunology Research | January 21, 2026 | Volume: 14 | Issue: 4 | Pages: 658-675

10.1158/2326-6066.cir-25-0567 | PMID 41564348 Get It

Abstract Lung cancer is the leading cause of cancer-related deaths worldwide, and despite advances in treatment, immune suppression remains an obstacle to effective therapy. Effector CD4+ T cells (CD4+ Teff) are critical for antitumor immunity, but their function is often inhibited by regulatory T cells (Treg), which accumulate in lung tumors and mediate suppressive functions through multiple mechanisms. This suppression leads to tumor progression and poor patient outcomes. However, the mechanisms underlying Treg-mediated suppression are not fully understood. Herein, we identify the extracellular adenosine 5-triphosphate receptor P2RX7 as a key regulator of Treg function in lung tumors. In a murine lung cancer model induced by Lewis lung carcinoma cells, we found that P2RX7 enhanced the suppressive capacity of tumor-infiltrating Tregs, promoting tumor growth. In T cell–specific P2RX7-knockout (P2RX7-KO) mice, reduced Treg infiltration was accompanied by increased CD4+ Teff accumulation and improved tumor control. Treg-specific P2RX7-KO mice exhibited reduced tumor growth, confirming a Treg-intrinsic role of P2RX7. Suppression assays revealed that tumor-infiltrating wild-type Tregs had greater suppressive activity compared with P2RX7-KO Tregs, which failed to inhibit type 1 and follicular helper T–like responses. This was associated with increased tumor-specific IgG production by lung B cells in P2RX7-KO mice. We also observed that wild-type Tregs expressed higher levels of the immunosuppressive molecule CTLA-4 when compared with P2RX7-KO Tregs. Thus, we conclude that P2RX7 expression on Tregs is essential for their suppressive function in lung cancer and targeting P2RX7 may constitute a strategy to improve lung cancer treatment by alleviating Treg-mediated immune suppression.
Septic Arthritis Secondary to Acupuncture in an Immunocompromised Patient With Multiple Comorbid Conditions
Lester, Peyton R., Baptista, Aleksandra Murawska , Stoll, Nicolas Tapia, Skinner, PW, Singla, Abhinav , Murawska Baptista, Aleksandra, Tapia Stoll, Nicolas , Skinner, Preston , Lester, Peyton R., Stoll, Nicolas Tapia

Mayo Clinic

American Journal of Case Reports | December 8, 2025 | Volume: 27 | Issue: No issue available | Pages: No page available

10.12659/ajcr.948392 | PMID 41572597 Get It

Expression of the extracellular ATP sensor P2RX7 promotes the accumulation of pro-tumorigenic regulatory T cells inside lung tumors 3161
Junior, Ronaldo Silva, Johnston, Tyler , Stoll, Carly R. , Souza, Fabio Carvalho de, Santiago-Carvalho, Igor , Macedo, Bruna de Gois , Salgado, Caio Loureiro , Junior, Ronaldo Silva, White, Emily, Johnston, Tyler, Souza, Fabio Carvalho de, Silva, Ildefonso , Lancaster, Jessica N. , Silva, Henrique Borges da

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.993 Get It

Abstract Description The presence of Foxp3+CD4+ regulatory T cells (Tregs) hinders the protective antitumor T cell responses to lung cancer. The accumulation of Tregs is linked to lung cancer progression, resulting in poorer survival rates. However, the mechanisms behind this accumulation are not fully understood. Tregs express elevated levels of the extracellular ATP (eATP) receptor P2RX7 in both human and mouse lung cancer. Here, we show that P2RX7 is crucial for the accumulation of Tregs in lung tumor, promoting tumor growth in a murine lung cancer model. We observed, in T cell-specific P2RX7-KO mice (CD4-cre P2rx7fl/fl), reduced Treg infiltration and a concomitant increase in tumor CD4+ effector T cells, leading to better tumor control. In contrast, P2RX7-KO Tregs accumulated in mediastinal lymph nodes, suggesting that blocking P2RX7-KO signaling impairs the Tregs migratory ability. P2RX7+ Tregs had increased expression of T-bet and KLRG1, which are associated with greater suppressive function. Finally, Treg-specific P2RX7-KO mice (Foxp3-Cre-ERT2 P2rx7fl/fl) had reduced tumor growth and Treg tumor accumulation, indicating that P2RX7 controls lung tumor Tregs in a cell-intrinsic way. These results suggest that P2RX7 promotes lung tumor Treg infiltration and subsequent loss of cancer control. They also suggest that P2RX7 blockade can be used as a therapy to improve lung cancer control, which we are currently exploring in proof-of-concept experiments. Funding Sources Mayo Clinic and National Institutes of Health (NIH - H.B.d.S.: R01 AI170649) Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)
Schwannoma Presenting as Infectious Fluid Collection
Stoll, Rebecca , Davis, Fred, Spurlock, Katherine, Schupack, Katie M., Miller, Nathaniel E. , Miller, Nathaniel E , Davis, Fred

Mayo Clinic

Journal of Primary Care & Community Health | September 16, 2025 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/21501319251378358 | PMID 40956946 Get It

A 33-year-old female presented with finger pain, swelling, and erythema was diagnosed with cellulitis and treated with antibiotics. Persistent symptoms led to further evaluation including a point-of-care ultrasound revealing a cystic structure, concerning for abscess. Incision and drainage yielded a solid mass rather than fluid. Pathological examination revealed a schwannoma, a benign peripheral nerve sheath tumor. This case highlights the rare presentation of a schwannoma mimicking an infectious process and emphasizes the importance of considering peripheral nerve tumors in the differential diagnosis of soft tissue masses, especially when the clinical course is atypical. It also underscores the value of pathological examination in establishing a definitive diagnosis and preventing misdiagnosis, which can have implications for patient management.
The Society of Pediatric Liver Transplantation ( SPLIT ): 2023 Registry Status
Banc‐Husu, Anna M. , Smith, Rachel , Kelly, Beau , Anand, Ravinder , Anderson, Sarah G. , Lobritto, Steven , Chapin, Catherine A. , Chartier, Marie‐Eve , Ekong, Udeme D. , Furuya, Katryn N. , García, Jennifer , González‐Peralta, Regino P. , Ibrahim, Samar H. , Kerkar, Nanda , Leung, Daniel H. , Ng, Vicky L. , Pai, Anita K., Pan, Debra H. , Shakhin, Victoria , Stoll, Janis , Wadera, Sheetal, Squires, James E. , (SPLIT), the Society of Pediatric Liver Transplantation, Lobritto, Steve , Elisofon, Scott A , Feldman, Amy , Gutierrez Sanchez, Luz Helena , Hildreth, Amber N , Himes, Ryan , Ibrahim, Samar H , Kerkar, Nanda , Leung, Daniel H , Mazareigos, George , Ng, Vicky L , Peters, Anna L , Shakhin, Victoria , Hsu, Evelyn , Squires, James E , Valentino, Pamela , Society of Pediatric Liver Transplantation (SPLIT) , Sanchez, Luz Helena Gutierrez , Hildreth, Amber , Jain, Ajay K. , Mazariegos, George , Valentino, Pamela L. , (SPLIT), the Society of Pediatric Liver Transplantation

Mayo Clinic

Pediatric Transplantation | June 16, 2025 | Volume: 29 | Issue: 5 | Pages: No page available

10.1111/petr.70111 | PMID 40522021 Get It

ABSTRACT Background The Society of Pediatric Liver Transplantation (SPLIT) has undergone tremendous growth with > 45 sites contributing data focusing on improving outcomes in pediatric liver transplantation (LT). We report and compare outcomes from the SPLIT Registry. Methods Patients < 18 years with first‐time LT only enrolled into the SPLIT Registry between 2011 and 2023 were included. Data was stratified into eras from the last published registry update (era 1: 2011–2018, era 2: 2018–2023). Results Three thousand five hundred four participants from 47 centers were included (era 1: n = 2159; era 2: n = 1345). Age distribution differed with more children < 1 year. of age at LT in era 2 (era 1: 29% vs. era 2: 33%, p = 0.01). Indications for LT were similar, with biliary atresia (38.8%) and metabolic disease (16.0%) being most common. Exception point use was higher in era 2 (era 1: 45% vs. era 2: 56%, p < 0.001). No difference in graft type (deceased: 81% era 1 vs. 78% era 2, p = 0.78), patient survival at 90 days (era 1: 98.7% vs. era 2: 98.3%), 1 year (era 1: 97.2 vs. era 2: 96.8%), or 3 years (era 1: 95.3% vs. era 2: 95.2%) was noted. Rate of hepatic artery thrombosis was lower in era 2 (era 1: 7% vs. era 2: 5%, p = 0.02). Conclusions Trends in pediatric LT within SPLIT note similar LT indications and graft type, higher utilization of exception points, and lower HAT rates despite transplanting more children < 10 kg. This data underscores the evolution of pediatric LT toward higher survivability and overall patient outcomes.